Form 4: InfuSystem Holdings CEO Richard Dilorio Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
InfuSystem Holdings CEO Richard Dilorio sold a total of 40,000 shares of common stock between November 25th and November 27th, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Richard Dilorio, CEO of InfuSystem Holdings, sold 40,000 shares of common stock over three days.
- The sales occurred between November 25th and November 27th, 2024.
- The shares were sold under a pre-arranged Rule 10b5-1 trading plan adopted on August 23, 2024.
- On November 25th, 20,000 shares were sold at a weighted average price of $9.3208.
- On November 26th, 14,602 shares were sold at a weighted average price of $8.9142.
- On November 27th, 5,398 shares were sold at a weighted average price of $8.8708.
- Following these transactions, Dilorio directly owns 416,659 shares of InfuSystem Holdings common stock, which includes 885 shares acquired through the Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction under a pre-arranged trading plan. It is neither particularly positive nor negative from an investment perspective.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
Industry Context
Executive stock sales are a common occurrence, especially when conducted under pre-arranged trading plans like 10b5-1 plans, which are designed to avoid accusations of insider trading. This activity is not unusual and is often part of an executive's personal financial planning.
Comparison to Industry Standards
- Executive stock sales are a common practice across publicly traded companies.
- The use of 10b5-1 trading plans is a standard method for executives to sell shares without raising concerns about insider trading.
- The volume of shares sold by Mr. Dilorio is not unusual for a CEO of a company of this size.
Stakeholder Impact
- The stock sales may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date the 10b5-1 trading plan was adopted by Richard Dilorio. |
| 11/25/2024 | Date of the first stock sale, 20,000 shares at $9.3208. |
| 11/26/2024 | Date of the second stock sale, 14,602 shares at $8.9142. |
| 11/27/2024 | Date of the third stock sale, 5,398 shares at $8.8708. |
Keywords
InfuSystem Holdings, Richard Dilorio, stock sale, 10b5-1 plan, executive stock, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.